Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3)

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3)

 EDITORIAL RADIOPHARMACOLOGY - RECENT DEVELOPMENTS IN THE FIELD OF RADIOPHARMACEUTICALS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):239-40

Radiopharmacology: recent developments in the field of radiopharmaceuticals

Cutler C. S.


 REVIEWS RADIOPHARMACOLOGY - RECENT DEVELOPMENTS IN THE FIELD OF RADIOPHARMACEUTICALS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):241-68

Prostate-specific membrane antigen as a target for cancer imaging and therapy

Kiess A. P., Banerjee S. R., Mease R. C., Rowe S. P., Rao A., Foss C. A., Chen Y., Yang X., Cho S. Y., Nimmagadda S., Pomper M. G.


 REVIEWS RADIOPHARMACOLOGY - RECENT DEVELOPMENTS IN THE FIELD OF RADIOPHARMACEUTICALS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):269-86

Preclinical development of small-molecular-weight folate-based radioconjugates: a pharmacological perspective

Siwowska K., Müller C.


 REVIEWS RADIOPHARMACOLOGY - RECENT DEVELOPMENTS IN THE FIELD OF RADIOPHARMACEUTICALS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):287-302

Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting

Kaloudi A., Nock B. A., Krenning E. P., Maina T., De Jong M.


 REVIEWS RADIOPHARMACOLOGY - RECENT DEVELOPMENTS IN THE FIELD OF RADIOPHARMACEUTICALS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):303-16

Preclinical imaging and treatment of cancer: the use of animal models beyond rodents

Axiak-Bechtel S. M., Maitz C. A., Selting K. A., Bryan J. N.


 REVIEWS RADIOPHARMACOLOGY - RECENT DEVELOPMENTS IN THE FIELD OF RADIOPHARMACEUTICALS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):317-26

Preclinical testing of radiopharmaceuticals for novel applications in HIV, bacterial and fungal infectious diseases

Shah M., Garg G., Dadachova E.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):327-35

Detection of extranodal spread in head and neck cancer with [18F]FDG PET and MRI: improved accuracy?

Lodder W. L., Vogel W. V., Lange C. A., Hamming-Vrieze O., Van Velthuysen M.-L., Pameijer F. A., Balm A. J., Van Den Brekel M. W.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):336-41

Estimation of coronary flow reserve by sestamibi imaging in patients with mild hypertension and normal coronary arteries

Storto G., Gallicchio R., Maddalena F., Pellegrino T., Petretta M., Fiumara G., Cuocolo A.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):342-50

11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning

Garcia J. R., Jorcano S., Soler M., Linero D., Moragas M., Riera E., Miralbell R., Lomeña F.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):351-6

A bone metastases model of anaplastic thyroid carcinoma in athymic nude mice

Zhang L., Wang H., Liang S., Ma C.


inizio pagina